PMC:7546122 / 10086-10722 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T50","span":{"begin":23,"end":29},"obj":"Body_part"},{"id":"T51","span":{"begin":85,"end":91},"obj":"Body_part"},{"id":"T52","span":{"begin":520,"end":526},"obj":"Body_part"}],"attributes":[{"id":"A50","pred":"fma_id","subj":"T50","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A51","pred":"fma_id","subj":"T51","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A52","pred":"fma_id","subj":"T52","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. Further positive pools were found in weeks 15, 16, 24, and 28. Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T43","span":{"begin":223,"end":231},"obj":"Disease"},{"id":"T44","span":{"begin":324,"end":332},"obj":"Disease"},{"id":"T45","span":{"begin":468,"end":476},"obj":"Disease"},{"id":"T46","span":{"begin":552,"end":560},"obj":"Disease"},{"id":"T47","span":{"begin":597,"end":605},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. Further positive pools were found in weeks 15, 16, 24, and 28. Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T101","span":{"begin":0,"end":7},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T102","span":{"begin":8,"end":9},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T103","span":{"begin":23,"end":29},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T104","span":{"begin":85,"end":91},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T105","span":{"begin":440,"end":446},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T106","span":{"begin":520,"end":526},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T107","span":{"begin":571,"end":572},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. Further positive pools were found in weeks 15, 16, 24, and 28. Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T69","span":{"begin":0,"end":284},"obj":"Sentence"},{"id":"T70","span":{"begin":285,"end":360},"obj":"Sentence"},{"id":"T71","span":{"begin":361,"end":423},"obj":"Sentence"},{"id":"T72","span":{"begin":424,"end":636},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. Further positive pools were found in weeks 15, 16, 24, and 28. Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"181","span":{"begin":223,"end":233},"obj":"Species"},{"id":"182","span":{"begin":324,"end":334},"obj":"Species"},{"id":"183","span":{"begin":468,"end":478},"obj":"Species"},{"id":"184","span":{"begin":552,"end":562},"obj":"Species"},{"id":"185","span":{"begin":316,"end":320},"obj":"Chemical"},{"id":"186","span":{"begin":460,"end":464},"obj":"Chemical"},{"id":"187","span":{"begin":597,"end":605},"obj":"Disease"}],"attributes":[{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"Tax:2697049"},{"id":"A182","pred":"tao:has_database_id","subj":"182","obj":"Tax:2697049"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"Tax:2697049"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Tax:2697049"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. Further positive pools were found in weeks 15, 16, 24, and 28. Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1)."}